Clinical Report: Pediatric Vascular Behçet’s Disease with Arterial Involvement
Overview
This case series presents five female pediatric patients with vascular Behçet’s disease (VBD), highlighting universal arterial involvement. The study aims to enhance understanding of the clinical features and management strategies.
Background
Vascular Behçet’s disease is a rare subtype of Behçet disease characterized by vascular inflammation, with limited data on its presentation in the pediatric population. Understanding the clinical features and long-term outcomes of VBD is crucial for enhancing recognition and management strategies in affected children.
Data Highlights
Patient
Age
Clinical Features
Treatment
Follow-up Outcome
1
10
Erythema nodosum, oral ulcers
Glucocorticoids + Immunosuppressants
Significant improvement
2
12
Abdominal pain, fever
Glucocorticoids + Biologics
Resolution of vascular lesions
3
13
Genital ulcers, joint symptoms
Glucocorticoids + Immunosuppressants
Amelioration on imaging
4
14
Persistent fever, hematochezia
Glucocorticoids + Biologics
Intestinal ulcers healed
5
15
Skin breakdown, sore throat
Glucocorticoids + Immunosuppressants
Significant clinical improvement
Key Findings
All five patients exhibited universal arterial involvement with lesions in various artery sizes.
Clinical manifestations included mucocutaneous symptoms such as erythema nodosum and oral ulcers.
All patients responded favorably to glucocorticoids combined with immunosuppressants or biologic agents.
Laboratory evaluations showed elevated inflammatory markers in all cases.
Follow-up imaging demonstrated resolution or significant amelioration of vascular lesions.
Clinical Implications
Clinicians should be aware of the potential for vascular involvement in pediatric patients with Behçet’s disease.
Conclusion
This case series highlights the arterial involvement in pediatric vascular Behçet’s disease. Increased awareness is essential for improving patient recognition.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
